GlassScriptPhysician profile
Melanie Gonzalez
NPI 1992185763
$5,472.27
in general payments reported to CMS, 2019-2025
47 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $251 · 2021: $422 · 2022: $804 · 2023: $790 · 2024: $815 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,029 · Travel and Lodging: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,029.43 |
| Travel and Lodging | $270.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $962.71 | 2019-2024 | |
| Osteomed LLC | $482.01 | 2019 | |
| Organogenesis INC. | $414.14 | 2023-2025 | Puraply Wound Matrix, Nushield, Puraply Antimicrobial |
| Abbvie INC. | $408.93 | 2021-2025 | |
| Horizon Therapeutics Plc | $284.97 | 2019-2022 | |
| Smith+Nephew, INC. | $278.78 | 2019-2025 | Q-Fix, Na, N/A |
| Nevro Corp. | $230.71 | 2022-2024 | Senza |
| Stryker Corporation | $214.92 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $210.47 | 2021-2025 | Nuzyra |
| Triad Life Sciences INC. | $165.72 | 2022 | |
| Kerecis Limited | $152.65 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Surgenex LLC | $147.19 | 2025 | Renograft, Surgraft, Ardeograft |
| Acumed LLC | $140.96 | 2025 | Acumed, Innate Implant |
| Melinta Therapeutics, LLC | $123.79 | 2019-2023 | Kimyrsa |
| Averitas Pharma INC. | $121.74 | 2023 | Qutenza |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $109.88 | 2023-2024 | |
| Depuy Synthes Sales INC. | $108.12 | 2021-2023 | N/A, Fibergraft Bg Morsels, Motoband Cp |
| Vaporox, INC. | $92.28 | 2023 | Vht-200 Wound Treatment System |
| Ani Pharmaceuticals, INC. | $62.25 | 2025 | Purified Cortrophin Gel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.31 | 2019-2021 | |
| Tactile Systems Technology INC | $54.42 | 2023 | Flexitouch Plus, Entre Plus |
| Kowa Pharmaceuticals America, INC. | $48.17 | 2022-2023 | Seglentis |
| Merck Sharp & Dohme LLC | $38.38 | 2019 | |
| Boston Scientific Corporation | $37.50 | 2023 | |
| Integra Lifesciences Corporation | $36.63 | 2020-2023 | Tenoglide |
| Acera Surgical, INC. | $35.25 | 2022-2025 | Restrata Wound Matrix |
| Tenex Health INC. | $34.06 | 2021 | |
| Baudax Bio INC. | $31.75 | 2021 | |
| Bioventus LLC | $31.68 | 2019 | |
| Allergan, INC. | $30.74 | 2020 | |
| Dynasplint Systems INC. | $29.78 | 2025 | Dynasplint |
| Nabriva Therapeutics, Plc | $28.60 | 2021-2022 | |
| Medtronic, INC. | $25.80 | 2024 | Intellis Adaptivestim |
| Aroa Biosurgery Incorporated | $25.68 | 2020 | |
| Grt US Holding, INC. | $22.08 | 2022 | |
| Aesculap, INC. | $21.07 | 2024 | Elan 4 |
| Polynovo North America LLC | $21.01 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $20.66 | 2021 | |
| Heron Therapeutics, INC. | $20.26 | 2025 | Zynrelef |
| Biowound Solutions, INC. | $17.28 | 2024 | Bio-Connekt |
| Biotissue Holdings INC. | $16.15 | 2023 | |
| Hartmann USA, INC. | $15.43 | 2021 | |
| Zyla Life Sciences, INC. | $14.50 | 2019 | |
| Kci USA, INC. | $13.67 | 2019 | |
| Wright Medical Technology, INC. | $13.30 | 2020 | |
| Linvatec Corporation | $13.18 | 2022 | |
| Novastep INC. | $7.71 | 2023 | Peca Bunion Correction System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.